G TREEBNT CO LTD has a total of 21 patent applications. It increased the IP activity by 14.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are NATURE TECHNOLOGY INC, PDS BIOTECHNOLOGY CORP and EUROCINE AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Materials and metallurgy | |
#5 | Engines, pumps and turbines | |
#6 | Thermal processes |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Non-metallic elements | |
#6 | Medical purpose containers | |
#7 | Fluid heaters | |
#8 | Non-positive-displacement pumps |
# | Name | Total Patents |
---|---|---|
#1 | Kim Kyoungsun | 15 |
#2 | Lee Si Young | 12 |
#3 | Um Tae Heum | 9 |
#4 | Sung Ji Hye | 7 |
#5 | Kang Sin Wook | 7 |
#6 | Yang Wonsuk | 6 |
#7 | Sung Jihye | 6 |
#8 | Choi Jun Won | 6 |
#9 | Kang Sinwook | 6 |
#10 | Lee Hee Jin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019103523A2 | Composition for promoting goblet cell proliferation or mucin secretion comprising thymosin beta 4 or derivative thereof as active ingredient | |
KR20190119847A | Housing for boiler pumps | |
KR20180101024A | Stabilized topical composition comprising thymosin beta 4 as an active ingredient | |
EP3338792A1 | Corneal damage prevention/treatment composition comprising thymosin beta 4 and citric acid as active ingredients | |
EP3342398A1 | Method for preparing ophthalmic preparation containing thymosin beta-4 | |
EP3210614A1 | Composition containing thymosin beta 4, and pharmaceutical formulation comprising same |